Plain-English translation of NCT04160715 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This is a registry study โ essentially a research database โ that collects medical information from people with idiopathic pulmonary fibrosis (a progressive lung condition where lung tissue becomes scarred over time). Doctors from 30 hospitals across Korea are gathering information about patients' symptoms, lung function tests, blood work, chest scans, and medical histories. This shared information will help researchers understand the disease better and develop better treatments.
Idiopathic pulmonary fibrosis is a serious condition that affects many people, but doctors still have a lot to learn about how it progresses and who responds best to different treatments. By collecting detailed information from a large group of Korean patients in one place, researchers hope to find patterns that will improve diagnosis, treatment, and care.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
Your participation involves allowing doctors to collect and record information about your health. This may include your basic health information, results from lung function tests you've already had or will have, blood work, chest CT scan images, and notes about your treatment and hospital visits. The study does not involve taking a new medication or undergoing extra procedures โ it simply gathers information from your existing medical care.
AI-generated summary from trial data ยท Jun 17, 2026 ยท Not medical advice
South Korea
Sponsor
Seoul National University Hospital
Enrollment target
~3,000 participants
Started
January 2016
Primary completion
January 2025
This trial's estimated completion date has passed โ the record may not be fully up to date.
Age range
30 Years โ 100 Years
Last updated on clinicaltrials.gov in November 2019.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Jong Sun Park, MD
Samsung Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.